nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—SCNN1A—Stimuli-sensing channels—TRPV1—atherosclerosis	0.0204	0.0478	CbGpPWpGaD
Triamterene—SCNN1G—Stimuli-sensing channels—TRPV1—atherosclerosis	0.0204	0.0478	CbGpPWpGaD
Triamterene—SCNN1D—Stimuli-sensing channels—TRPV1—atherosclerosis	0.0204	0.0478	CbGpPWpGaD
Triamterene—SCNN1B—Stimuli-sensing channels—TRPV1—atherosclerosis	0.0204	0.0478	CbGpPWpGaD
Triamterene—Renal failure acute—Rosuvastatin—atherosclerosis	0.0197	0.0343	CcSEcCtD
Triamterene—Photosensitivity—Lovastatin—atherosclerosis	0.0176	0.0306	CcSEcCtD
Triamterene—Photosensitivity—Ezetimibe—atherosclerosis	0.0172	0.03	CcSEcCtD
Triamterene—Photosensitivity—Simvastatin—atherosclerosis	0.0164	0.0286	CcSEcCtD
Triamterene—Photosensitivity—Pravastatin—atherosclerosis	0.0148	0.0259	CcSEcCtD
Triamterene—Renal failure acute—Pravastatin—atherosclerosis	0.0141	0.0246	CcSEcCtD
Triamterene—Jaundice—Rosuvastatin—atherosclerosis	0.0137	0.0238	CcSEcCtD
Triamterene—SCNN1D—Ion channel transport—TRPV1—atherosclerosis	0.0133	0.0312	CbGpPWpGaD
Triamterene—SCNN1A—Ion channel transport—TRPV1—atherosclerosis	0.0133	0.0312	CbGpPWpGaD
Triamterene—SCNN1G—Ion channel transport—TRPV1—atherosclerosis	0.0133	0.0312	CbGpPWpGaD
Triamterene—SCNN1B—Ion channel transport—TRPV1—atherosclerosis	0.0133	0.0312	CbGpPWpGaD
Triamterene—Photosensitivity reaction—Lovastatin—atherosclerosis	0.0122	0.0212	CcSEcCtD
Triamterene—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.0119	0.0208	CcSEcCtD
Triamterene—Photosensitivity reaction—Simvastatin—atherosclerosis	0.0114	0.0198	CcSEcCtD
Triamterene—Jaundice—Ezetimibe—atherosclerosis	0.0114	0.0198	CcSEcCtD
Triamterene—Jaundice—Simvastatin—atherosclerosis	0.0108	0.0189	CcSEcCtD
Triamterene—Photosensitivity reaction—Pravastatin—atherosclerosis	0.0103	0.0179	CcSEcCtD
Triamterene—Jaundice—Niacin—atherosclerosis	0.00994	0.0173	CcSEcCtD
Triamterene—Jaundice—Pravastatin—atherosclerosis	0.00979	0.0171	CcSEcCtD
Triamterene—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00875	0.0153	CcSEcCtD
Triamterene—Dry mouth—Lovastatin—atherosclerosis	0.00773	0.0135	CcSEcCtD
Triamterene—Dry mouth—Ezetimibe—atherosclerosis	0.00758	0.0132	CcSEcCtD
Triamterene—Anaphylactic shock—Lovastatin—atherosclerosis	0.00758	0.0132	CcSEcCtD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.00749	0.0176	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.00749	0.0176	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.00749	0.0176	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.00749	0.0176	CbGpPWpGaD
Triamterene—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00743	0.013	CcSEcCtD
Triamterene—Thrombocytopenia—Lovastatin—atherosclerosis	0.00742	0.0129	CcSEcCtD
Triamterene—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00727	0.0127	CcSEcCtD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.00718	0.0168	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.00718	0.0168	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.00718	0.0168	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.00718	0.0168	CbGpPWpGaD
Triamterene—Anaphylactic shock—Simvastatin—atherosclerosis	0.00709	0.0124	CcSEcCtD
Triamterene—Thrombocytopenia—Simvastatin—atherosclerosis	0.00694	0.0121	CcSEcCtD
Triamterene—Dry mouth—Niacin—atherosclerosis	0.00664	0.0116	CcSEcCtD
Triamterene—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00659	0.0115	CcSEcCtD
Triamterene—Fatigue—Lovastatin—atherosclerosis	0.00653	0.0114	CcSEcCtD
Triamterene—Anaphylactic shock—Niacin—atherosclerosis	0.00651	0.0113	CcSEcCtD
Triamterene—Asthenia—Rosuvastatin—atherosclerosis	0.00641	0.0112	CcSEcCtD
Triamterene—Anaphylactic shock—Pravastatin—atherosclerosis	0.00641	0.0112	CcSEcCtD
Triamterene—Fatigue—Ezetimibe—atherosclerosis	0.00641	0.0112	CcSEcCtD
Triamterene—Thrombocytopenia—Pravastatin—atherosclerosis	0.00627	0.0109	CcSEcCtD
Triamterene—Diarrhoea—Rosuvastatin—atherosclerosis	0.00612	0.0107	CcSEcCtD
Triamterene—Fatigue—Simvastatin—atherosclerosis	0.00611	0.0106	CcSEcCtD
Triamterene—Dizziness—Rosuvastatin—atherosclerosis	0.00591	0.0103	CcSEcCtD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.00568	0.0133	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.00568	0.0133	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.00568	0.0133	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.00568	0.0133	CbGpPWpGaD
Triamterene—Rash—Rosuvastatin—atherosclerosis	0.00564	0.00983	CcSEcCtD
Triamterene—Dermatitis—Rosuvastatin—atherosclerosis	0.00563	0.00982	CcSEcCtD
Triamterene—Headache—Rosuvastatin—atherosclerosis	0.0056	0.00976	CcSEcCtD
Triamterene—Hypersensitivity—Lovastatin—atherosclerosis	0.00558	0.00973	CcSEcCtD
Triamterene—Fatigue—Pravastatin—atherosclerosis	0.00552	0.00963	CcSEcCtD
Triamterene—Hypersensitivity—Ezetimibe—atherosclerosis	0.00547	0.00954	CcSEcCtD
Triamterene—Asthenia—Lovastatin—atherosclerosis	0.00544	0.00948	CcSEcCtD
Triamterene—Asthenia—Ezetimibe—atherosclerosis	0.00533	0.00929	CcSEcCtD
Triamterene—Nausea—Rosuvastatin—atherosclerosis	0.00531	0.00926	CcSEcCtD
Triamterene—Hypersensitivity—Simvastatin—atherosclerosis	0.00522	0.0091	CcSEcCtD
Triamterene—Diarrhoea—Lovastatin—atherosclerosis	0.00518	0.00904	CcSEcCtD
Triamterene—SCNN1B—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.00515	0.0121	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.00515	0.0121	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.00515	0.0121	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.00515	0.0121	CbGpPWpGaD
Triamterene—Asthenia—Simvastatin—atherosclerosis	0.00508	0.00886	CcSEcCtD
Triamterene—Diarrhoea—Ezetimibe—atherosclerosis	0.00508	0.00886	CcSEcCtD
Triamterene—Dizziness—Lovastatin—atherosclerosis	0.00501	0.00873	CcSEcCtD
Triamterene—Dizziness—Ezetimibe—atherosclerosis	0.00491	0.00857	CcSEcCtD
Triamterene—Diarrhoea—Simvastatin—atherosclerosis	0.00485	0.00845	CcSEcCtD
Triamterene—Vomiting—Lovastatin—atherosclerosis	0.00482	0.0084	CcSEcCtD
Triamterene—Hypersensitivity—Niacin—atherosclerosis	0.00479	0.00836	CcSEcCtD
Triamterene—Rash—Lovastatin—atherosclerosis	0.00478	0.00833	CcSEcCtD
Triamterene—Dermatitis—Lovastatin—atherosclerosis	0.00477	0.00832	CcSEcCtD
Triamterene—Headache—Lovastatin—atherosclerosis	0.00475	0.00827	CcSEcCtD
Triamterene—Vomiting—Ezetimibe—atherosclerosis	0.00472	0.00824	CcSEcCtD
Triamterene—Hypersensitivity—Pravastatin—atherosclerosis	0.00472	0.00823	CcSEcCtD
Triamterene—CYP1A2—Aflatoxin B1 metabolism—GSTM1—atherosclerosis	0.00469	0.011	CbGpPWpGaD
Triamterene—Dizziness—Simvastatin—atherosclerosis	0.00469	0.00817	CcSEcCtD
Triamterene—Rash—Ezetimibe—atherosclerosis	0.00468	0.00817	CcSEcCtD
Triamterene—Dermatitis—Ezetimibe—atherosclerosis	0.00468	0.00816	CcSEcCtD
Triamterene—Asthenia—Niacin—atherosclerosis	0.00467	0.00814	CcSEcCtD
Triamterene—Headache—Ezetimibe—atherosclerosis	0.00465	0.00811	CcSEcCtD
Triamterene—SCNN1D—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.00463	0.0109	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.00463	0.0109	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.00463	0.0109	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.00463	0.0109	CbGpPWpGaD
Triamterene—Asthenia—Pravastatin—atherosclerosis	0.0046	0.00801	CcSEcCtD
Triamterene—Vomiting—Simvastatin—atherosclerosis	0.00451	0.00785	CcSEcCtD
Triamterene—Nausea—Lovastatin—atherosclerosis	0.0045	0.00784	CcSEcCtD
Triamterene—Rash—Simvastatin—atherosclerosis	0.00447	0.00779	CcSEcCtD
Triamterene—Dermatitis—Simvastatin—atherosclerosis	0.00446	0.00778	CcSEcCtD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.00446	0.0104	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.00446	0.0104	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.00446	0.0104	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.00446	0.0104	CbGpPWpGaD
Triamterene—Diarrhoea—Niacin—atherosclerosis	0.00445	0.00776	CcSEcCtD
Triamterene—Headache—Simvastatin—atherosclerosis	0.00444	0.00774	CcSEcCtD
Triamterene—Nausea—Ezetimibe—atherosclerosis	0.00441	0.00769	CcSEcCtD
Triamterene—Diarrhoea—Pravastatin—atherosclerosis	0.00438	0.00764	CcSEcCtD
Triamterene—Dizziness—Niacin—atherosclerosis	0.0043	0.0075	CcSEcCtD
Triamterene—Dizziness—Pravastatin—atherosclerosis	0.00424	0.00738	CcSEcCtD
Triamterene—Nausea—Simvastatin—atherosclerosis	0.00421	0.00734	CcSEcCtD
Triamterene—Vomiting—Niacin—atherosclerosis	0.00414	0.00721	CcSEcCtD
Triamterene—Rash—Niacin—atherosclerosis	0.0041	0.00715	CcSEcCtD
Triamterene—Dermatitis—Niacin—atherosclerosis	0.0041	0.00714	CcSEcCtD
Triamterene—Headache—Niacin—atherosclerosis	0.00408	0.00711	CcSEcCtD
Triamterene—Vomiting—Pravastatin—atherosclerosis	0.00407	0.0071	CcSEcCtD
Triamterene—Rash—Pravastatin—atherosclerosis	0.00404	0.00704	CcSEcCtD
Triamterene—Dermatitis—Pravastatin—atherosclerosis	0.00404	0.00703	CcSEcCtD
Triamterene—Headache—Pravastatin—atherosclerosis	0.00401	0.007	CcSEcCtD
Triamterene—Nausea—Niacin—atherosclerosis	0.00386	0.00674	CcSEcCtD
Triamterene—Nausea—Pravastatin—atherosclerosis	0.00381	0.00663	CcSEcCtD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.00354	0.0083	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—CETP—atherosclerosis	0.0033	0.00773	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—CETP—atherosclerosis	0.0033	0.00773	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—CETP—atherosclerosis	0.0033	0.00773	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—CETP—atherosclerosis	0.0033	0.00773	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—LTA4H—atherosclerosis	0.00329	0.00771	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.00321	0.00753	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.00291	0.00682	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.00291	0.00682	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.00291	0.00682	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.00291	0.00682	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.00278	0.00651	CbGpPWpGaD
Triamterene—CYP1A2—Estrogen Receptor Pathway—PPARA—atherosclerosis	0.00248	0.00581	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—PLG—atherosclerosis	0.00247	0.0058	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—PLG—atherosclerosis	0.00247	0.0058	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—PLG—atherosclerosis	0.00247	0.0058	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—PLG—atherosclerosis	0.00247	0.0058	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.00228	0.00535	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.00228	0.00535	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.00228	0.00535	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.00228	0.00535	CbGpPWpGaD
Triamterene—CYP1A2—Estrogen Receptor Pathway—ESR1—atherosclerosis	0.00225	0.00527	CbGpPWpGaD
Triamterene—CYP1A2—Estrogen metabolism—GSTM1—atherosclerosis	0.0022	0.00517	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—APOB—atherosclerosis	0.00218	0.00512	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—APOB—atherosclerosis	0.00218	0.00512	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—APOB—atherosclerosis	0.00218	0.00512	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—APOB—atherosclerosis	0.00218	0.00512	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—ALOX5AP—atherosclerosis	0.00207	0.00484	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—ALOX15—atherosclerosis	0.00207	0.00484	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.00204	0.00478	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.00201	0.00472	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—atherosclerosis	0.00193	0.00452	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—AHR—atherosclerosis	0.00193	0.00452	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.00188	0.00442	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.00186	0.00436	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.00184	0.00432	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.00184	0.00432	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.00184	0.00432	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.00184	0.00432	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—ALOX5—atherosclerosis	0.00176	0.00412	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.00173	0.00405	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.00173	0.00405	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.00173	0.00405	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.00173	0.00405	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.00166	0.00389	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.00165	0.00387	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.00153	0.00358	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—EDN1—atherosclerosis	0.00152	0.00357	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ALB—atherosclerosis	0.00137	0.00321	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ALB—atherosclerosis	0.00137	0.00321	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ALB—atherosclerosis	0.00137	0.00321	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ALB—atherosclerosis	0.00137	0.00321	CbGpPWpGaD
Triamterene—CYP1A2—Estrogen Receptor Pathway—STAT3—atherosclerosis	0.00126	0.00295	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—APOE—atherosclerosis	0.00124	0.0029	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.00115	0.00269	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—LPL—atherosclerosis	0.00102	0.0024	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—CD36—atherosclerosis	0.00097	0.00228	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.00095	0.00223	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—GPX1—atherosclerosis	0.000932	0.00219	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP7A1—atherosclerosis	0.000877	0.00206	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000865	0.00203	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—atherosclerosis	0.000817	0.00192	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP27A1—atherosclerosis	0.000811	0.0019	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP27A1—atherosclerosis	0.0008	0.00188	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—NFKB1—atherosclerosis	0.000736	0.00173	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTM1—atherosclerosis	0.000619	0.00145	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atherosclerosis	0.000612	0.00143	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—atherosclerosis	0.000587	0.00138	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000577	0.00135	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—PTGS2—atherosclerosis	0.000549	0.00129	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atherosclerosis	0.000546	0.00128	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000542	0.00127	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	0.000509	0.00119	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.00047	0.0011	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.00047	0.0011	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	0.000462	0.00108	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	0.000424	0.000995	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	0.000396	0.000929	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	0.000396	0.000929	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000372	0.000872	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTM1—atherosclerosis	0.000362	0.00085	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTM1—atherosclerosis	0.000357	0.000838	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000349	0.000819	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000349	0.000819	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000343	0.000804	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000337	0.00079	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000311	0.00073	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000295	0.000692	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000295	0.000692	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000295	0.000692	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000295	0.000692	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000292	0.000684	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000282	0.000661	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.00027	0.000633	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.00026	0.00061	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	0.000257	0.000602	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000251	0.000589	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PLTP—atherosclerosis	0.000241	0.000566	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000224	0.000525	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000222	0.000521	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000221	0.000518	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000216	0.000506	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LTA4H—atherosclerosis	0.000209	0.000491	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ABCG8—atherosclerosis	0.000209	0.000491	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000207	0.000485	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000195	0.000458	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000174	0.000408	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ABCG1—atherosclerosis	0.000165	0.000388	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LCAT—atherosclerosis	0.000156	0.000365	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—FABP4—atherosclerosis	0.000156	0.000365	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOA4—atherosclerosis	0.000153	0.000358	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP7A1—atherosclerosis	0.00015	0.000352	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000143	0.000335	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP27A1—atherosclerosis	0.000139	0.000325	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000137	0.00032	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000133	0.000312	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	0.000131	0.000308	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOA2—atherosclerosis	0.000131	0.000308	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALOX15—atherosclerosis	0.000131	0.000308	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	0.000131	0.000308	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ABCG5—atherosclerosis	0.00013	0.000305	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.00013	0.000304	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LPA—atherosclerosis	0.000125	0.000294	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—BGN—atherosclerosis	0.000121	0.000285	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000121	0.000283	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOA5—atherosclerosis	0.00012	0.000282	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000117	0.000274	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	0.000116	0.000271	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000114	0.000268	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000113	0.000266	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000113	0.000265	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALOX5—atherosclerosis	0.000112	0.000262	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000103	0.000242	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NAMPT—atherosclerosis	0.0001	0.000235	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	9.97e-05	0.000234	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LIPC—atherosclerosis	9.96e-05	0.000234	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOC3—atherosclerosis	9.9e-05	0.000232	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LDLR—atherosclerosis	9.84e-05	0.000231	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CETP—atherosclerosis	9.61e-05	0.000225	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SCARB1—atherosclerosis	9.21e-05	0.000216	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.96e-05	0.00021	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HMGCR—atherosclerosis	8.69e-05	0.000204	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.84e-05	0.000184	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ABCA1—atherosclerosis	7.75e-05	0.000182	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HMOX1—atherosclerosis	6.65e-05	0.000156	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOB—atherosclerosis	6.37e-05	0.000149	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTM1—atherosclerosis	6.19e-05	0.000145	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—LPL—atherosclerosis	6.08e-05	0.000143	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GPX1—atherosclerosis	5.93e-05	0.000139	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CD36—atherosclerosis	5.78e-05	0.000135	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MTHFR—atherosclerosis	5.47e-05	0.000128	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PPARA—atherosclerosis	5.37e-05	0.000126	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AGT—atherosclerosis	5.2e-05	0.000122	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOE—atherosclerosis	5.1e-05	0.00012	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CAV1—atherosclerosis	5.05e-05	0.000118	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOA1—atherosclerosis	5.04e-05	0.000118	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PIK3CG—atherosclerosis	4.6e-05	0.000108	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PPARG—atherosclerosis	4.44e-05	0.000104	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—INS—atherosclerosis	4.35e-05	0.000102	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ALB—atherosclerosis	3.99e-05	9.36e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NOS3—atherosclerosis	3.82e-05	8.96e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.49e-05	8.19e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—AKT1—atherosclerosis	1.76e-05	4.12e-05	CbGpPWpGaD
